17. Clinical Course
- The patient initially did not respond well to IVIG and Solu-Medrol, but did transiently increase his platelet count after platelet transfusion on day 11 (see next graph).
- Imuran added on day 19 caused a significant increase in his count, allowing him to be discharged from the hospital.
- He relapsed on day 31, received Vincristine, and had an excellent response.